Human Longevity Stock

www.humanlongevity.com | BioTech | Founded: 2013 | Funding to Date: $49,298,124

Human Longevity is a genomics-based, health intelligence company creating the world’s largest and most comprehensive database of whole genome, phenotype and clinical data.

ENTERPRISE VALUE (based on primary fundings)

Human Longevity investors also invested in these private companies

Amino Capital
Celgene
Draper Fisher Jurvetson
Synthetic Genomics
StartUp Health

TEAM

Management Team
  • J. Venter - Co-founder and CEO
  • Yaron Turpaz - Chief Information Officer
  • Felix Frueh - Chief Scientific Officer
  • Williams Biggs - Head, Genomic Sequencing
Board Members
  • Eric Anderson - Intentional Software
  • David Brenner - University of California, San Diego
  • James Brewer - University of California, San Diego
  • Delos Cosgrove - Cleveland Clinic

Other companies like Human Longevity in the BioTech sector

Ginkgo Bioworks
BioTech
Est. Val.: $4.89B
Caribou Biosciences
BioTech
Est. Val.: $143,800,000
Life Biosciences
BioTech
Est. Val.: $500,000,000
American Gene Technologies International
BioTech
Est. Val.: $265,000,000
Mammoth Biosciences
BioTech
Est. Val.: $145,000,000

NEWS

X